Associated Papers
Clinically relevant glioblastoma patient-derived xenograft models to guide drug development and identify molecular signatures.
Alcaniz J et al.
Frontiers in Oncology, 2023
37114125 (PubMed )
Supplement: Table_1.xlsx › Mutations
The impact of heterogeneity in phosphoinositide 3-kinase pathway in human cancer and possible therapeutic treatments.
Wang W et al.
Seminars in Cell & Developmental Biology, 2017
Prediction for response duration to epidermal growth factor receptor-tyrosine kinase inhibitors in EGFR mutated never smoker lung adenocarcinoma.
Kim HR et al.
Lung Cancer (amsterdam, Netherlands), 2014
Select a paper to view details